Physician profile
Anjali A Pathak
NPI 1558448928
$15,555.62
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $97.58 · 2021: $52.13 · 2022: $23.96 · 2023: $4,410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,123 · Food and Beverage: $223 · Travel and Lodging: $64.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,122.50 |
| Food and Beverage | $222.84 |
| Travel and Lodging | $64.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $6,798.65 | 2019 | |
| Idorsia Pharmaceuticals US INC | $4,199.86 | 2023 | Quviviq |
| Tris Pharma INC | $3,393.27 | 2019-2020 | |
| Allergan, INC. | $323.84 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $209.31 | 2019-2023 | Rexulti |
| Avanir Pharmaceuticals, INC. | $144.88 | 2019-2020 | |
| Abbvie INC. | $137.73 | 2021-2023 | |
| Teva Pharmaceuticals USA, INC. | $101.10 | 2019-2020 | |
| Alkermes, INC. | $52.41 | 2019 | |
| Janssen Pharmaceuticals, INC | $48.60 | 2019-2021 | |
| Lundbeck LLC | $43.12 | 2019 | |
| Neuronetics, INC. | $31.00 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.63 | 2019 | |
| Bausch Health US, LLC | $15.61 | 2019 | |
| Neos Therapeutics, LP | $13.31 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $12.30 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anjali Pathak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.